Naohiko Akimoto
Naohiko Akimoto publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Screening and Detection and Gastrointestinal Tumor Research and Treatment.
- World rank
- #596,087 of 7,710,434 ranked researchers
- Rank in Japan
- #6,517 of 383,136
- Works
- 128
- Citations
- 2.3k
- Citations per work
- 17.9
What does Naohiko Akimoto research?
Naohiko Akimoto's work is mostly in Medicine (70%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences9070.2%
- Medicine9070.2%
- Everything else3124.2%
- Life Sciences75.6%
- 1Oncology23% of their works
- 2Pulmonary and Respiratory Medicine17% of their works
- 3Surgery17% of their works
- 4Gastroenterology8% of their works
- 5Immunology6% of their works
- 6Pathology and Forensic Medicine6% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Screening and Detection
- Gastrointestinal Tumor Research and Treatment
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
- Genetic factors in colorectal cancer
- Colorectal Cancer Treatments and Studies
- Esophageal Cancer Research and Treatment
Which keywords describe Naohiko Akimoto's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Molecular Characterization, Chemotherapy, Endoscopic Resection, Gastric Cancer, Lymph Node Dissection, Adjuvant Chemotherapy and Neoadjuvant Therapy.
- Barrett's Esophagus
- Cetuximab
- Hereditary Syndromes
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Imatinib Mesylate
- Colorectal Cancer
- Neoadjuvant Therapy
- Lymph Node Dissection
- Endoscopic Resection
- Molecular Characterization
- Clinical Practice Guidelines
- Chemotherapy
- Gastric Cancer
- Adjuvant Chemotherapy
- Preoperative Chemoradiotherapy
- Screening
- Sunitinib
- Laparoscopic Surgery
- Rectal Cancer
- Microsatellite Instability
- KRAS Mutations
- Esophageal Carcinoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Clinical Practice Guidelines442 topics
- Molecular Characterization432 topics
- Chemotherapy392 topics
- Endoscopic Resection382 topics
- Gastric Cancer301 topic
- Lymph Node Dissection301 topic
- Adjuvant Chemotherapy272 topics
- Neoadjuvant Therapy222 topics
- Preoperative Chemoradiotherapy222 topics
- Colorectal Cancer201 topic
- Screening201 topic
- Imatinib Mesylate171 topic
- Sunitinib171 topic
- Immune Checkpoint Blockade141 topic
- Laparoscopic Surgery141 topic
- PD-1 and PD-L1141 topic
- Rectal Cancer141 topic
- Hereditary Syndromes131 topic
- Microsatellite Instability131 topic
- Cetuximab91 topic
- KRAS Mutations91 topic
- Barrett's Esophagus81 topic
- Esophageal Carcinoma81 topic
Where does Naohiko Akimoto work?
Naohiko Akimoto's main affiliation in the publication record is Nippon Medical School, Japan.
How many publications and citations does Naohiko Akimoto have?
OpenAlex counts 128 works and 2,286 citations for Naohiko Akimoto, an h-index of 21, ranking #596,087 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Naohiko Akimoto. Posts are plain text and can be reported.